Literature DB >> 22265700

Chronic insomnia.

Charles M Morin1, Ruth Benca.   

Abstract

Insomnia is a prevalent complaint in clinical practice that can present independently or comorbidly with another medical or psychiatric disorder. In either case, it might need treatment of its own. Of the different therapeutic options available, benzodiazepine-receptor agonists (BzRAs) and cognitive-behavioural therapy (CBT) are supported by the best empirical evidence. BzRAs are readily available and effective in the short-term management of insomnia, but evidence of long-term efficacy is scarce and most hypnotic drugs are associated with potential adverse effects. CBT is an effective alternative for chronic insomnia. Although more time consuming than drug management, CBT produces sleep improvements that are sustained over time, and this therapy is accepted by patients. Although CBT is not readily available in most clinical settings, access and delivery can be made easier through use of innovative methods such as telephone consultations, group therapy, and self-help approaches. Combined CBT and drug treatment can optimise outcomes, although evidence to guide clinical practice on the best way to integrate these approaches is scarce. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265700     DOI: 10.1016/S0140-6736(11)60750-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  203 in total

1.  Lack of Resilience Is Related to Stress-Related Sleep Reactivity, Hyperarousal, and Emotion Dysregulation in Insomnia Disorder.

Authors:  Laura Palagini; Umberto Moretto; Martina Novi; Isabella Masci; Danila Caruso; Christopher L Drake; Dieter Riemann
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 2.  Insomnia in the Elderly: A Review.

Authors:  Dhaval Patel; Joel Steinberg; Pragnesh Patel
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

3.  Long-Term Effects of an Unguided Online Cognitive Behavioral Therapy for Chronic Insomnia.

Authors:  Øystein Vedaa; Susanne Hagatun; Håvard Kallestad; Ståle Pallesen; Otto R F Smith; Frances P Thorndike; Lee M Ritterband; Børge Sivertsen
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

Review 4.  Comorbid Insomnia and Psychiatric Disorders: An Update.

Authors:  Khurshid A Khurshid
Journal:  Innov Clin Neurosci       Date:  2018-04-01

5.  Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep.

Authors:  Bende Zou; William S Cao; Zhiwei Guan; Kui Xiao; Conrado Pascual; Julian Xie; Jingxi Zhang; James Xie; Frank Kayser; Craig W Lindsley; C David Weaver; Jidong Fang; Xinmin Simon Xie
Journal:  Sleep       Date:  2019-03-01       Impact factor: 5.849

Review 6.  The pathophysiology of insomnia.

Authors:  Jessica C Levenson; Daniel B Kay; Daniel J Buysse
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

7.  Therapeutic application of melatonin in mild cognitive impairment.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Analía M Furio; Luis I Brusco
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  Sleep Related Cognitions in Individuals with Symptoms of Insomnia and Depression.

Authors:  Jessica C Levenson; Ruth M Benca; Meredith E Rumble
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

9.  Relationship between sleep disturbance and recovery in patients with borderline personality disorder.

Authors:  David T Plante; Frances R Frankenburg; Garrett M Fitzmaurice; Mary C Zanarini
Journal:  J Psychosom Res       Date:  2013-02-11       Impact factor: 3.006

Review 10.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.